ZA959729B - Immunogenic compositions - Google Patents

Immunogenic compositions

Info

Publication number
ZA959729B
ZA959729B ZA959729A ZA959729A ZA959729B ZA 959729 B ZA959729 B ZA 959729B ZA 959729 A ZA959729 A ZA 959729A ZA 959729 A ZA959729 A ZA 959729A ZA 959729 B ZA959729 B ZA 959729B
Authority
ZA
South Africa
Prior art keywords
immunogenic compositions
immunogenic composition
solubilised
immunogen
absence
Prior art date
Application number
ZA959729A
Other languages
English (en)
Inventor
Roger Randal Charles New
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of ZA959729B publication Critical patent/ZA959729B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA959729A 1994-11-15 1995-11-15 Immunogenic compositions ZA959729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions

Publications (1)

Publication Number Publication Date
ZA959729B true ZA959729B (en) 1997-05-15

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959729A ZA959729B (en) 1994-11-15 1995-11-15 Immunogenic compositions

Country Status (19)

Country Link
EP (1) EP0792165B1 (de)
JP (1) JP4297515B2 (de)
KR (1) KR970706848A (de)
CN (1) CN100346828C (de)
AT (1) ATE249841T1 (de)
AU (1) AU700910B2 (de)
CA (1) CA2205083A1 (de)
DE (1) DE69531793T2 (de)
DK (1) DK0792165T3 (de)
ES (1) ES2210318T3 (de)
FI (1) FI972054A0 (de)
GB (1) GB9422990D0 (de)
IL (1) IL116010A0 (de)
MX (1) MX9703480A (de)
NO (1) NO972219L (de)
NZ (1) NZ295238A (de)
PT (1) PT792165E (de)
WO (1) WO1996014871A1 (de)
ZA (1) ZA959729B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
UY25089A1 (es) * 1997-07-10 2000-08-21 Hoechst Roussel Vet Gmbh Vacunas no acuosas
BR9907885A (pt) * 1998-02-12 2000-11-14 American Cyanamid Co Composição de vacina, processo para fazer surgir uma resposta imune a um antìgeno de vìrus sincicial respiratório, e, composição imunogênica
IL137809A0 (en) * 1998-02-12 2001-10-31 American Cyanamid Co Pneumococcal and meningococcal vaccines formulated with interleukin-12
ATE275421T1 (de) * 1998-02-12 2004-09-15 Wyeth Corp Interleukin-12 und herpes simplex virusantigen enthaltende impfstoffe
WO1999056776A2 (en) 1998-05-07 1999-11-11 Corixa Corporation Adjuvant composition and methods for its use
EP1097715A4 (de) 1998-07-16 2004-12-29 Hayashi Akira Arzneimittel zur immuntherapie gegen krebs enthaltend einen bakteriellen somatischen bestandteil als aktiven inhaltsstoff
EP2197497B1 (de) 2007-09-27 2016-06-01 ImmunoVaccine Technologies Inc. Verwendung von liposomen in einem träger mit einer kontinuierlichen hydrophoben phase zur abgabe von polynucleotiden in vivo
CA2700828C (en) * 2007-10-03 2017-01-24 Immunovaccine Technologies Inc. Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
CN102056622B (zh) 2008-06-05 2016-04-06 免疫疫苗技术有限公司 包含脂质体、抗原、多核苷酸和含疏水物质的连续相的载体的组合物
US20140004141A1 (en) * 2010-12-23 2014-01-02 Immport Therapeutics, Inc. Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
BR112014007927B1 (pt) 2011-10-06 2021-04-13 Immunovaccine Technologies Inc Composições de lipossoma compreendendo um adjuvante e usos das referidas composições e usos das referidas composições

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
ATE233547T1 (de) * 1991-06-26 2003-03-15 Yamanouchi Europ Bv Vesiculae in nichtpolaren medien
JPH09501169A (ja) * 1993-08-06 1997-02-04 オパーバス ホールディング ビー ヴィ 小胞に生体高分子物質を高度に充填する方法
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
DE69531793D1 (de) 2003-10-23
EP0792165A1 (de) 1997-09-03
CN1163575A (zh) 1997-10-29
GB9422990D0 (en) 1995-01-04
JP4297515B2 (ja) 2009-07-15
IL116010A0 (en) 1996-01-31
NZ295238A (en) 1999-01-28
CA2205083A1 (en) 1996-05-23
PT792165E (pt) 2004-02-27
MX9703480A (es) 1997-08-30
CN100346828C (zh) 2007-11-07
AU3853495A (en) 1996-06-06
ES2210318T3 (es) 2004-07-01
FI972054A (fi) 1997-05-14
FI972054A0 (fi) 1997-05-14
WO1996014871A1 (en) 1996-05-23
ATE249841T1 (de) 2003-10-15
DK0792165T3 (da) 2004-01-05
EP0792165B1 (de) 2003-09-17
AU700910B2 (en) 1999-01-14
NO972219L (no) 1997-07-11
KR970706848A (ko) 1997-12-01
JPH10508834A (ja) 1998-09-02
DE69531793T2 (de) 2004-07-15
NO972219D0 (no) 1997-05-14

Similar Documents

Publication Publication Date Title
ZA959729B (en) Immunogenic compositions
WO1997001640A3 (en) Vaccines against hepatitis c
GR3025184T3 (en) Vaccine composition containing adjuvants.
CA2217178A1 (en) Vaccines containing a saponin and a sterol
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
AU7546887A (en) Variants of lav viruses, their dna- and protein-components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions
AU6913687A (en) Solid antitartar mouth deodorant composition
CA2177668A1 (en) Mammalian vaccine compositions comprising squalene or squalane, glycerol and a surfactant as an adjuvant
AU4622693A (en) Potentiation of immunogenic response
DZ2283A1 (fr) Composition de vaccin.
EP1891968A3 (de) Rotavirusimpfstoff-Formulierungen
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
CA2068431A1 (en) Stabilized stannous fluoride compositions for oral care
CA2216410A1 (en) Improved inactivated vaccines
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
AU4450696A (en) Enhanced immunogenic vaccine
AU8204887A (en) Conjugate vaccine
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
AU2901997A (en) Immunogenic complex, use, method of preparation thereof and vaccine containing same
AU7528087A (en) Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it
EG20082A (en) Process for preparing of octadecyl-(2-N-methylpiperidino)-ethyl-phosphate
AU7249491A (en) Improved immunogenic compositions
AU8235291A (en) Lyophilized native collagen sheets comprising cosmetic formulations for the treatment of couperose